CerRx
Lubbock
About CerRx
CerRx Inc. engages in the discovery and development of anticancer drugs for cancer patients. Its products include Fenretinide, a synthetic molecule that increases ceramide waxes and kills cancer cells; and Safingol, an artificial ceramide precursor that increases killing of fenretinide in cancer cells. The company was founded in 2008 and is based in Lubbock, Texas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.1M
- Last round: Series Unknown (Feb 2013)
- Website: cerrx.com
- Phone: 806-780-6068
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/cerrx-2798472 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.